Macular Degeneration Treatment Market by Drug Class (Anti-VEGFs and Other Drugs), by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)), by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

Name: Macular Degeneration Treatment Market by Drug Class (Anti-VEGFs and Other Drugs), by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)), by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032
Creator: www.zionmarketresearch.com
Published: 2024-11-25 00:00:00
License: 暂无描述

www.zionmarketresearch.com2024-11-25 更新2025-03-23 收录

下载链接：

https://www.zionmarketresearch.com/report/macular-degeneration-treatment-market

下载链接

链接失效反馈

官方服务：

资源简介：

The global Macular Degeneration Treatment Market size was valued USD 10.02 billion in 2023 and is expected to rise to USD 20.54 billion by 2032 at a CAGR of 8.3%.

2023年，全球黄斑变性治疗市场规模估值达到1002亿美元，预计到2032年将增至2054亿美元，年复合增长率达到8.3%。

提供机构：